Clinical Trial Update: CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CD62L-depleted donor lymphocyte infusion with T cell-depleted haploidentical hematopoietic stem cell transplantation is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Disorders

Drugs mentioned

• CD62L Depleted Donor Lymphocyte Infusion
• T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Snippet

Sponsor: Hong Kong Children's Hospital | Conditions: Hematopoietic Organs; Disorder | Phase 2 | Status: RECRUITING